Mon, August 15, 2022
Fri, August 12, 2022
Thu, August 11, 2022
Wed, August 10, 2022

Leland Gershell Maintained (ASND) at Buy with Decreased Target to $144 on, Aug 11th, 2022


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. th-decreased-target-to-144-on-aug-11th-2022.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Leland Gershell of Oppenheimer, Maintained "Ascendis Pharma A/S" (ASND) at Buy with Decreased Target from $154 to $144 on, Aug 11th, 2022.

Leland has made no other calls on ASND in the last 4 months.



There are 3 other peers that have a rating on ASND. Out of the 3 peers that are also analyzing ASND, 0 agree with Leland's Rating of Hold.



These are the ratings of the 3 analyists that currently disagree with Leland


  • David Lebowitz of "Citigroup" Maintained at Strong Buy with Decreased Target to $158 on, Thursday, May 12th, 2022
  • Derek Archila of "Wells Fargo" Maintained at Buy with Decreased Target to $176 on, Thursday, May 12th, 2022
  • Tiago Fauth of "Credit Suisse" Maintained at Buy with Decreased Target to $123 on, Thursday, May 12th, 2022

Publication Contributing Sources